Granon 3mg/3ml injection
Dexa Medica
Ingredients in every 3 ml
| Granisetron | 3 mg |
Each package contains
Other details
| Flavour | None |
W.H.O. classification
| ATC Level 1 | A - Alimentary tract and metabolism |
| ATC Level 2 | A04 - Antiemetics and Antinauseants |
| ATC Level 3 | A04A - Antiemetics and Antinauseants |
Warnings
Pregnancy
Lactation
Alcohol
Machinery
Available in
 |
Indonesia |
Dosage information
18 YEARS OLD AND ABOVE
Chemotherapy induced nausea and vomiting (CINV) Intravenous:
Prevention: 1-3 mg (10-40 mcg/kg) as a slow intravenous injection (over 30 seconds) or as an intravenous infusion diluted in 20 to 50 ml infusion fluid and administered over 5 minutes, prior to the start of chemotherapy.
Treatment: 1-3 mg (10-40 mcg/kg) as a slow intravenous injection (over 30 seconds) or as an intravenous infusion diluted in 20 to 50 ml infusion fluid and administered over 5 minutes.
Maximum dose over 24 hours: 9 mg.
Chemotherapy induced nausea and vomiting (CINV) Intramuscular:
Prevention and treatment: 3 mg, 15 minutes prior to the start of chemotherapy.
Radiotherapy induced nausea and vomiting (RINV):
Prevention: 1-3 mg (10-40 mcg/kg) of granisetron should be administered either as a slow intravenous injection (over 30 seconds) or as an intravenous infusion diluted in 20 to 50 ml infusion fluid and administered over 5 minutes, prior to the start of radiotherapy.
Post-operative nausea and vomiting (PONV):
Prevention: 1 mg (10 mcg/kg) of granisetron should be administered as a slow intravenous injection (over 30 seconds) prior to induction of anesthesia.
Treatment: 1 mg (10 mcg/kg) of granisetron should be administered by slow intravenous injection (over 30 seconds).
Maximum dose for patients undergoing anesthesia for surgery: 3 mg in one day.
0 TO 18 YEARS OLD
Chemotherapy induced nausea and vomiting (CINV) Intravenous:
10-40 mcg/kg body weight (up to 3 mg) as an intravenous infusion diluted in 10-30 ml infusion fluid and administered over 5 minutes prior to the start of chemotherapy.
Chemotherapy induced nausea and vomiting (CINV) Intramuscular:
Insufficient data.
Radiotherapy induced nausea and vomiting (RINV): Insufficient data.
Post-operative nausea and vomiting (PONV): Insufficient data.
Indication
Granisetron is indicated for the prevention and treatment (control) of:
– Acute and delayed nausea and vomiting associated with chemotherapy and radiotherapy.
– Postoperative nausea and vomiting.